/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Following his father's footsteps (Dr. Jean Bour, a cardiologist in France), Frank Bour dedicated his entire professional life to developing a technology (PhysioFlow®) for non-invasive haemodynamic monitoring at rest ad during exercise. He owns several patents, has been very involved in validation and applied research work, and leads the company that focuses on developing this technology and making it available to practitioners and research scientists world-wide.
Frank Bour is currently a 4th and final year member of the Paris University PhD programme (in exercise science) .
Signal morphology impedance cardiography is a tool to explain the response of cardiac patients to cardiac rehabilitation in the presence of altered myocardial contractility profiles
Event: ESC Preventive Cardiology 2025
Topic: Outcomes
Session: Cardiovascular rehabilitation: best practice (2)
